Labplus

Labplus is a Polish startup offering medical-grade software that interprets laboratory test results based on each patient’s individual context. The company has developed the world's first certified medical software that automatically interprets laboratory test results, providing personalized interpretations. By analyzing test results and patient responses from a remote medical questionnaire, the tool generates customized insights regarding the patient's health status, the need for further diagnostics, recommended tests, and preventive care. This interpretation facilitates self-monitoring of health status and timely medical assistance. Labplus has made significant strides by collaborating with reputable laboratories, including Diagnostyka, Vitalabo, Śląskie Laboratoria Analityczne, and others, which collectively represent 40% of the Polish market. Founded in 2018, Labplus operates in the industries of AI, Health Care, Health and Wellness, Internet, and Medical Devices. The company recently secured a PLN7.00M Pre Seed Round investment on 01 December 2021 from Movens Capital and LT Capital. With its innovative approach and strategic partnerships, Labplus is positioning itself as a disruptive force in the healthcare technology industry, aiming to improve patient outcomes and revolutionize the way laboratory test results are interpreted and utilized for personalized care.